Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90

被引:43
|
作者
Meiby, Elinor [1 ]
Simmonite, Heather [2 ]
le Strat, Loic [2 ]
Davis, Ben [2 ]
Matassova, Natalia [2 ]
Moore, Jonathan D. [2 ]
Mrosek, Michael [2 ]
Murray, James [2 ]
Hubbard, Roderick E. [2 ,3 ]
Ohlson, Sten [1 ,4 ]
机构
[1] Linnaeus Univ, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden
[2] Vernalis, Cambridge CB21 6GB, England
[3] Univ York, YSBL, York YO10 5DD, N Yorkshire, England
[4] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore
关键词
INHIBITORS; DISCOVERY; LIGAND; BINDING; IDENTIFICATION; PROTEINS; DESIGN;
D O I
10.1021/ac400715t
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The increasing use of fragment-based lead discovery (FBLD) in industry as well as in academia creates a high demand for sensitive and reliable methods to detect the binding of fragments to act as starting points in drug discovery programs. Nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), and X-ray crystallography are well-established methods for fragment finding, and thermal shift and fluorescence polarization (FP) assays are used to a lesser extent. Weak affinity chromatography (WAC) was recently introduced as a new technology for fragment screening. The study presented here compares screening of 111 fragments against the ATPase domain of HSP90 by all of these methods, with isothermal titration calorimetry (ITC) used to confirm the most potent hits. The study demonstrates that WAC is comparable to the established methods of ligand-based NMR and SPR as a hit-id method, with hit correlations of 88% and 83%, respectively. The stability of HSP90 WAC columns was also evaluated and found to give 90% reproducibility even after 207 days of storage. A good correlation was obtained between the various technologies, validating WAC as an effective technology for fragment screening.
引用
收藏
页码:6756 / 6766
页数:11
相关论文
共 50 条
  • [1] Advances with weak affinity chromatography for fragment screening
    Tsopelas, Fotios
    Tsantili-Kakoulidou, Anna
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (11) : 1125 - 1135
  • [2] Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening
    Roughley, Stephen
    Wright, Lisa
    Brough, Paul
    Massey, Andrew
    Hubbard, Roderick E.
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 61 - 82
  • [3] Weak affinity chromatography as a new approach for fragment screening in drug discovery
    Duong-Thi, Minh-Dao
    Meiby, Elinor
    Bergstrom, Maria
    Fex, Tomas
    Isaksson, Roland
    Ohlson, Sten
    ANALYTICAL BIOCHEMISTRY, 2011, 414 (01) : 138 - 146
  • [4] Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors
    Haginaka, Jun
    Kitabatake, Tomoko
    Hirose, Iyo
    Matsunaga, Hisami
    Moaddel, Ruin
    ANALYTICAL BIOCHEMISTRY, 2013, 434 (01) : 202 - 206
  • [5] Fragment screening for drug leads by weak affinity chromatography (WAC-MS)
    Ohlson, Sten
    Minh-Dao Duong-Thi
    METHODS, 2018, 146 : 26 - 38
  • [6] Fragment screening of cyclin G-associated kinase by weak affinity chromatography
    Elinor Meiby
    Stefan Knapp
    Jonathan M. Elkins
    Sten Ohlson
    Analytical and Bioanalytical Chemistry, 2012, 404 : 2417 - 2425
  • [7] Fragment screening of cyclin G-associated kinase by weak affinity chromatography
    Meiby, Elinor
    Knapp, Stefan
    Elkins, Jonathan M.
    Ohlson, Sten
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2012, 404 (08) : 2417 - 2425
  • [8] Lipodisks integrated with weak affinity chromatography enable fragment screening of integral membrane proteins
    Duong-Thi, Minh-Dao
    Bergstrom, Maria
    Edwards, Katarina
    Eriksson, Jonny
    Ohlson, Sten
    Ying, Janet To Yiu
    Torres, Jaume
    Hernandez, Victor Agmo
    ANALYST, 2016, 141 (03) : 981 - 988
  • [9] A highly selective Hsp90 affinity chromatography resin with a cleavable linker
    Hughes, Philip F.
    Barrott, Jared J.
    Carlson, David A.
    Loiselle, David R.
    Speer, Brittany L.
    Bodoor, Khaldon
    Rund, Lauretta A.
    Haystead, Timothy A. J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (10) : 3298 - 3305
  • [10] High-throughput screening for Hsp90 ATPase inhibitors
    Avila, C
    Hadden, MK
    Ma, ZQ
    Kornilayev, BA
    Ye, QZ
    Blagg, BSJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (11) : 3005 - 3008